Start for free
Start for free
R

Renaissance

Europe, Vaud, Switzerland, Lausanne

Description

Renaissance is an investment foundation for pension funds investing in small and medium-sized enterprises.

Investor Profile

Renaissance has made 7 investments, with 0 in the past 12 months and 43% as lead.

Stage Focus

  • Series B (29%)
  • Series C (29%)
  • Series A (14%)
  • Convertible Note (14%)
  • Seed (14%)

Country Focus

  • Switzerland (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Life Science
  • Personal Health
  • Pharmaceutical
  • Software
  • Enterprise Software
  • Human Resources
  • Saas
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Renaissance frequently co-invest with?

BioMedPartners
BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 3
PolyTechnos Venture Partners
PolyTechnos Venture Partners
Europe, Bayern, Germany, Munich
Co-Investments: 2
Index Ventures
Index Ventures
North America, California, United States, San Francisco
Co-Investments: 2
IC
Initiative Capital
Europe, Alsace, France, Sausheim
Co-Investments: 1
VINCI CAPITAL
VINCI CAPITAL
Europe, Vaud, Switzerland, Lausanne
Co-Investments: 3
EDBI
EDBI
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Sofinnova Partners
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Roche Venture Fund
Roche Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Techno Venture Management
Techno Venture Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Sunstone Life Science Ventures
Sunstone Life Science Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 3

What are some of recent deals done by Renaissance?

GlassIG

Geneva, Geneve, Switzerland

GlassIG is an independent software vendor. Our aim is to provide market leading.

ComputerSmall and Medium BusinessesSoftware
SeedJun 7, 2017
Amount Raised: $2,384,062
Anergis

Epalinges, Vaud, Switzerland

Anergis discovers and develops allergy vaccines based on the technology of Contiguous Overlapping Peptides for ultra-fast desensitization.

BiotechnologyHealth CareLife ScienceMedicalPersonal Health
Series CApr 4, 2016
Amount Raised: $5,214,846
Anergis

Epalinges, Vaud, Switzerland

Anergis discovers and develops allergy vaccines based on the technology of Contiguous Overlapping Peptides for ultra-fast desensitization.

BiotechnologyHealth CareLife ScienceMedicalPersonal Health
Series BDec 3, 2014
Amount Raised: $14,889,494
Beqom

Fribourg, Fribourg, Switzerland

Beqom provides a total compensation cloud solution that addresses all aspects of compensation and performance for both sales and HR.

Enterprise SoftwareHuman ResourcesSaaSSoftware
Convertible NoteApr 1, 2014
Amount Raised: $10,600,000
Anergis

Epalinges, Vaud, Switzerland

Anergis discovers and develops allergy vaccines based on the technology of Contiguous Overlapping Peptides for ultra-fast desensitization.

BiotechnologyHealth CareLife ScienceMedicalPersonal Health
Series AFeb 7, 2014
Amount Raised: $8,897,618
Addex Therapeutics

Plan-les-ouates, Geneve, Switzerland

Addex Therapeutics is a biopharmaceutical company that discovers and develops allosteric modulators for human health.

BiotechnologyHealth CareMedicalPharmaceutical
Series CSep 19, 2006
Amount Raised: $31,688,931
Addex Therapeutics

Plan-les-ouates, Geneve, Switzerland

Addex Therapeutics is a biopharmaceutical company that discovers and develops allosteric modulators for human health.

BiotechnologyHealth CareMedicalPharmaceutical
Series BMay 17, 2004
Amount Raised: $39,644,926
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator